Trial intelligence / Profile preview

DENV-1-LVHC human challenge model assessment

NCT02372175Phase 1Completed

Sponsor
U.S. Army Medical Research and Development Command
Start
Oct 2015
Primary completion
Jun 2019
Modality
Oncolytic Viruses, Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 1, open-label trial of DENV-1-LVHC (strain 45AZ5) in dengue fever, sponsored by U.S. Army Medical Research and Development Command. Started Oct 2015; status: completed.

02

Drugs

DENV-1-LVHC (strain 45AZ5)
03

Conditions

dengue fever

Beyond the preview

Go deeper on NCT02372175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02372175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call